LeonaBio, Inc. (LONA)
NASDAQ: LONA · Real-Time Price · USD
3.880
-0.140 (-3.48%)
At close: Nov 11, 2026, 4:00 PM EST
3.910
+0.030 (0.77%)
After-hours: Nov 11, 2026, 7:30 PM EST
LeonaBio Market Cap
LeonaBio has a market cap or net worth of $36.56 million as of November 11, 2026. It is the 32,298th most valuable company in the world and the 4,790th biggest in the United States. Its market cap has increased by 102.38% in one year.
Market Cap
36.56M
Enterprise Value
-13.93M
1-Year Change
102.38%
Global Rank
Country Rank
#4,790 United States
Category
ChartMarket Cap Chart
Since September 18, 2020, LeonaBio's market cap has decreased from $527.32M to $36.56M, a decrease of -93.07%. That is a compound annual growth rate of -35.20%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 36.56M | 22.44% |
| Dec 31, 2025 | 29.86M | 31.60% |
| Dec 31, 2024 | 22.69M | -75.47% |
| Dec 29, 2023 | 92.47M | -22.89% |
| Dec 30, 2022 | 119.92M | -75.36% |
| Dec 31, 2021 | 486.68M | -56.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aldeyra Therapeutics | 39.30M |
| Grace Therapeutics | 39.02M |
| IRulya Therapeutics | 38.98M |
| Serina Therapeutics | 38.10M |
| eXoZymes | 37.13M |
| Impact BioMedical | 36.74M |
| Veru Inc. | 36.49M |
| Pelthos Therapeutics | 35.95M |